Travere Therapeutics Inc (TVTX) Insider Trading

Total insider buys:
  • $0.00
Total insider sells:
  • $18,684,763.79
Most recent insider trade:
  • Feb. 4, 2026
Most active insider trader:
  • Christopher R Cline
Trader NameDateTitleAmountPriceTypeTotal Value
Feb. 4, 2026Insider2,994$32.18Sell$96,346.92
Feb. 4, 2026CFO1,745$32.19Sell$56,171.55
Feb. 4, 2026Insider1,779$32.21Sell$57,301.59
Feb. 3, 2026Insider7,175$32.12Sell$230,461.00
Feb. 3, 2026CEO100,087$32.28Sell$3,230,808.36
Feb. 3, 2026CAO4,333$32.12Sell$139,175.96
Feb. 3, 2026CFO7,242$32.12Sell$232,613.04
Feb. 3, 2026Insider7,310$32.12Sell$234,797.20
Feb. 3, 2026Insider6,956$32.12Sell$223,426.72
Feb. 3, 2026Insider12,446$32.87Sell$409,100.02
Sept. 22, 2025Insider10,000$25.00Sell$250,000.00
Sept. 4, 2025CFO119$19.71Sell$2,345.49
Sept. 3, 2025CFO454$18.20Sell$8,262.80
July 1, 2025Insider815$14.65Sell$11,939.75
May 5, 2025CEO18,924$21.05Sell$398,350.20
May 5, 2025CFO1,784$21.05Sell$37,553.20
May 5, 2025Insider1,771$21.05Sell$37,279.55
April 11, 2025CFO48$13.14Sell$630.72
Feb. 12, 2025SVP5,200$23.53Sell$122,356.00
Feb. 11, 2025Insider3,074$25.00Sell$76,850.00
Feb. 11, 2025CAO54,244$25.00Sell$1,356,100.00
Feb. 11, 2025CEO11,375$24.04Sell$273,455.00
Feb. 6, 2025Director10,000$22.00Sell$220,000.00
Feb. 3, 2025CFO5,192$20.12Sell$104,463.04
Feb. 3, 2025SVP8,951$19.78Sell$177,050.78
Feb. 3, 2025CEO50,691$20.21Sell$1,024,465.11
Feb. 3, 2025CAO3,348$20.12Sell$67,361.76
Feb. 3, 2025Insider4,207$20.12Sell$84,644.84
Jan. 23, 2025Director16,000$20.00Sell$320,000.00
Jan. 22, 2025CFO865$18.94Sell$16,383.10
Jan. 22, 2025SVP2,437$19.46Sell$47,424.02
Jan. 22, 2025CAO925$18.94Sell$17,519.50
Jan. 22, 2025Insider1,584$18.94Sell$30,000.96
Jan. 22, 2025CEO10,736$19.46Sell$208,922.56
Jan. 6, 2025Insider440$18.76Sell$8,254.40
Jan. 3, 2025Insider2,066$19.10Sell$39,460.60
Dec. 26, 2024CAO15,000$17.22Sell$258,300.00
Nov. 25, 2024CAO12,090$18.30Sell$221,247.00
Oct. 4, 2024Director40,000$14.73Sell$589,200.00
Sept. 30, 2024Director40,000$14.06Sell$562,400.00
Sept. 9, 2024CFO2,490$11.52Sell$28,684.80
Sept. 9, 2024CEO21,125$11.52Sell$243,360.00
Sept. 9, 2024Insider2,191$11.52Sell$25,240.32
Sept. 9, 2024SVP4,387$11.52Sell$50,538.24
Sept. 4, 2024CFO514$9.51Sell$4,888.14
April 11, 2024CFO54$6.74Sell$363.96
Feb. 1, 2024CEO19,122$8.70Sell$166,361.40
Feb. 1, 2024CAO2,820$8.53Sell$24,054.60
Feb. 1, 2024Insider4,195$8.53Sell$35,783.35
Feb. 1, 2024CFO3,818$8.53Sell$32,567.54
First«1 of 3»Last
  • Insiders are selling Travere Therapeutics Inc stock.

  • The insider traders at Travere Therapeutics Inc are: Christopher R Cline, Eric M Dube, Sandra Calvin, Peter Heerma, William E Rote, Jula Inrig, Elizabeth E Reed, Steve Aselage, Laura Clague, Roy D Baynes, Noah L Rosenberg, Gary A Lyons, Jeffrey A Meckler, and Noah L. Rosenberg

  • The most active insider trader at Travere Therapeutics Inc is Christopher R Cline with 18 trades.

  • Eric M Dube has sold the most Travere Therapeutics Inc stock with a total value of $10,169,276.59.

  • The most recent insider trade for Travere Therapeutics Inc was on Feb. 4, 2026.

  • The single biggest insider sell for Travere Therapeutics Inc was from Eric M Dube with a total value of $3,230,808.36 on Feb. 3, 2026.